In another knockout approach, selective attenuation of the CS-E motif via siRNA targeting significantly reduces CSPG-mediated inhibition of

neurones in vitro [210]. Accordingly, neutralizing CS-E inhibition with a function blocking antibody led to increased regeneration following optic nerve crush [189]. Based on observations of collagenous scar deposition, early enzymatic attempts at matrix modification included hyaluronidase, trypsin and elastase application to the transected spinal cord which, although initially reported to promote recovery [211], lacked benefit in further studies Hormones antagonist and also caused vascular haemorrhage as a result of blood vessel basement membrane degradation [212–214]. The ECM has BEZ235 mw endogenous remodelling enzymes. Matrix metalloproteinases (MMPs) are a family of 24 (MMP 1-28) zinc- and calcium-dependent endopeptidases. They are divided into collagenases (MMP-1, -8, -13, -18), gelatinases (MMP-2 and -9), stromelysins (MMP-3, -10, -11), and membrane-type MMPs (MMP-14, -15, -16, -17, -24, -25) and other

MMPs. Generally they have three domains, an N-terminal propeptide domain, an internal catalytic (metalloproteinase) domain and a C-terminal haemopexin (haem binding) domain [215]. Collectively they can cleave all protein components of the ECM as well as other substrates including growth factors, cell adhesion molecules and receptors [216]. Their activity is highly regulated by steps within synthesis, post-translational modifications, release as inactive zymogens and inhibition by endogenous tissue inhibitors of metalloproteinases (TIMPs). The profile of almost all of the MMPs has been investigated after spinal cord injury (reviewed extensively in [217]) at an mRNA and protein level. Acutely, blockade of MMP-mediated BBB breakdown and leucocyte extravasation is thought to be of potential therapeutic benefit [218–220] and subsequent neuroimmunomodulatory effects of MMP-9 caudal to the lesion have been implicated [221]. MMP-9 knockout mice also have reduced motor

deficits following traumatic brain injury [222]. Anidulafungin (LY303366) In their traditional role as modulators of the ECM, some MMPs limit the formation of an inhibitory glial scar and degrade proteoglycans. For example, MMP-2 is known to degrade neurocan and versican and MMP-3 additionally degrades Tn-C, brevican, NG2 and phosphacan [223,224]. Accordingly, MMP-2 knockout mice have increased CSPG immunoreactivity, fewer serotonergic fibres caudal to the injury site, and significantly reduced motor recovery compared with wild-type mice following spinal contusion [225]. Fibroblasts genetically modified to secrete MMP-3 and transplanted following rat spinal contusion resulted in improved locomotor recovery compared with control fibroblasts, but not compared with other control groups [226].